Dana Farber Cancer Center to retract or fix dozens of studies
The Dana Farber Cancer Institute in Boston will retract six studies and correct 31 more as part of an ongoing investigation into claims of data manipulation.
Jan 23, 2024
1
50
Cardiovascular Diseases: News and Research on Hemostatic Disorders
MeSH tree: C14.907.454
Bone marrow adipocytes provide early sign of progression from MGUS to multiple myeloma
A new research perspective titled "Bone marrow adipocytes provide early sign for progression from mgus to multiple myeloma" has been published in Oncotarget.
Jan 22, 2024
0
36
Multiple myeloma cured after hepatitis treatment reveals that this cancer can be caused by viruses
A few years ago, a patient was cured of multiple myeloma after being treated for hepatitis C, astounding researchers from the group led by Joaquín Martínez, from the H12O-CNIO Hematological Tumours Clinical Research Unit, ...
Jan 19, 2024
0
150
Obesity linked to detection of blood cancer precursor
Individuals with obesity are more likely to have monoclonal gammopathy of undetermined significance (MGUS), a benign blood condition that often precedes multiple myeloma, according to new research published in Blood Advances.
Jan 12, 2024
0
100
Research group unveils the first individual risk prediction model for multiple myeloma
A multicenter collaboration has produced the first computational model for newly diagnosed multiple myeloma that predicts an individual's personalized prognosis based on their tumor genomics and treatments. The collaboration ...
Jan 9, 2024
0
44
Researchers develop 'potent and specific' compounds to curb cancer growth
Proteasomes are protein-degrading complexes that are important for cancer cell survival. Proteasome inhibitors are commonly used to treat diseases such as multiple myeloma and mantle cell lymphoma. Proteasomes have three ...
Dec 14, 2023
0
37
ASH: Daratumumab beneficial for patients with multiple myeloma
For transplantation-eligible patients with newly diagnosed multiple myeloma, the addition of subcutaneous daratumumab combined with bortezomib, lenalidomide, and dexamethasone induction and consolidation therapy and with ...
Dec 13, 2023
0
30
New hybrid treatment forces cancer cells to starve
The combination of a drug and a protein fragment prevents the growth of blood cancer cells, a new study in mice shows.
Dec 11, 2023
0
26
Q&A: How serious is FDA warning about revolutionary blood-cancer treatment?
The Food and Drug Administration announced last week that it's investigating reports of secondary cancers in patients who received CAR T-cell therapy, one of a suite of immunotherapies that have revolutionized cancer care ...
Dec 8, 2023
0
41
FDA is investigating whether CAR-T, a cancer therapy pioneered at Penn, can cause lymphoma
The University of Pennsylvania plans to continue offering CAR-T therapy, a cancer treatment pioneered at Penn, after the Food and Drug Administration announced an investigation into whether the treatment may cause cancer ...
Nov 29, 2023
0
85
